BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 9974173)

  • 1. Biochemistry of the endogenous ligands of cannabinoid receptors.
    Di Marzo V; Deutsch DG
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
    Di Marzo V
    Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
    Sugiura T; Kobayashi Y; Oka S; Waku K
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous cannabinoid signaling.
    Piomelli D; Beltramo M; Giuffrida A; Stella N
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):462-73. PubMed ID: 9974178
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells.
    Basavarajappa BS; Hungund BL
    J Neurochem; 1999 Feb; 72(2):522-8. PubMed ID: 9930723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptors and their endogenous ligands.
    Sugiura T; Waku K
    J Biochem; 2002 Jul; 132(1):7-12. PubMed ID: 12097154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues.
    Sugiura T; Kondo S; Sukagawa A; Tonegawa T; Nakane S; Yamashita A; Waku K
    J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):51-6. PubMed ID: 8906545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
    J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of endogenous cannabinoids.
    Martin BR; Mechoulam R; Razdan RK
    Life Sci; 1999; 65(6-7):573-95. PubMed ID: 10462059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite.
    Di Marzo V
    Biochemistry (Mosc); 1998 Jan; 63(1):13-21. PubMed ID: 9526090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?
    Burstein SH; Young JK; Wright GE
    Biochem Pharmacol; 1995 Nov; 50(11):1735-42. PubMed ID: 8615850
    [No Abstract]   [Full Text] [Related]  

  • 17. Anandamide--a new look on fatty acid ethanolamides.
    Berdyshev EV; Boichot E; Lagente V
    J Lipid Mediat Cell Signal; 1996 Dec; 15(1):49-67. PubMed ID: 9029374
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
    Romero J; Hillard CJ; Calero M; Rábano A
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):85-93. PubMed ID: 12008024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.